Saba Capital Management, L.P. Tekla Life Sciences Investors Transaction History
Saba Capital Management, L.P.
- $5.79 Billion
- Q1 2024
A detailed history of Saba Capital Management, L.P. transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Saba Capital Management, L.P. holds 2,462,147 shares of HQL stock, worth $34.7 Million. This represents 0.58% of its overall portfolio holdings.
Number of Shares
2,462,147
Previous 1,421,300
73.23%
Holding current value
$34.7 Million
Previous $19.1 Million
75.43%
% of portfolio
0.58%
Previous 0.39%
Shares
4 transactions
Others Institutions Holding HQL
# of Institutions
80Shares Held
8.51MCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY484KShares$6.83 Million0.0% of portfolio
-
1607 Capital Partners, LLC Richmond, VA481KShares$6.79 Million0.54% of portfolio
-
Allspring Global Investments Holdings, LLC431KShares$6.08 Million0.01% of portfolio
-
Aqr Arbitrage LLC Greenwich, CT387KShares$5.46 Million0.32% of portfolio
-
Karpus Management, Inc. Pittsford, NY346KShares$4.87 Million0.14% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...